Back to companies

Aptabio Therapeutics Inc.

293780KRKRX

압타바이오

Revenue
₩3.4bn
FY2024
Operating income
-₩18.9bn
FY2024
Employees
—
Founded
—

Source: Korea Financial Supervisory Service DART (Open DART API)